nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormal heart rate variability in adults with symptomatic growth hormone (GH) deficiency: improvement after 3 months of GH replacement therapy
|
Leong, K.S. |
|
2000 |
10 |
S2 |
p. S149- 1 p. |
artikel |
2 |
Acromegaly and primary hyperparathyroidism with multiple cancers of the lung, thyroid and breast: A case report
|
Miyachi, Y. |
|
2000 |
10 |
S2 |
p. S155- 1 p. |
artikel |
3 |
Acromegaly caused by ectopic growth hormone-releasinghormone secretion
|
Bonnin, C. |
|
2000 |
10 |
S2 |
p. S157- 1 p. |
artikel |
4 |
Adult patients with Prader-Willi syndrome: Clinical characteristics, life circumstances and growth hormone secretion
|
Partsch, C.A. |
|
2000 |
10 |
S2 |
p. S81-S85 5 p. |
artikel |
5 |
Assessment of growth hormone status in acromegaly: What biochemical markers to measure and how?
|
Camacho-Hübner, C. |
|
2000 |
10 |
S2 |
p. S125-S129 5 p. |
artikel |
6 |
A study of adult hypopituitarism in Northern Ireland: Results of a prolonged follow-up of 338 patients show increased mortality in both men and women
|
McConnell, E.M. |
|
2000 |
10 |
S2 |
p. S137- 1 p. |
artikel |
7 |
A switch from oral to transdermal 17β-oestradiol increases serum levels of insulin-like growth factor I in women with growth hormone (GH) deficiency receiving GH replacement therapy
|
Janssen, Y.J.H. |
|
2000 |
10 |
S2 |
p. S133- 1 p. |
artikel |
8 |
Cerebrovascular deaths in patients who underwent surgery and irradiation for a pituitary tumour
|
Erfurth, E.M. |
|
2000 |
10 |
S2 |
p. S154- 1 p. |
artikel |
9 |
Childhood- and adult-onset growth hormonedeficiency: Differences in cardiac function patterns in adults
|
Boquete, H. |
|
2000 |
10 |
S2 |
p. S148- 1 p. |
artikel |
10 |
Cognitive dysfunction in women withhypopituitarism
|
Bülow, B. |
|
2000 |
10 |
S2 |
p. S136- 1 p. |
artikel |
11 |
Combined Cushing's syndrome and acromegaly due to ectopic production of adrenocorticotropic hormone and growth hormone-releasing hormone
|
Jansson, J.-O. |
|
2000 |
10 |
S2 |
p. S157- 1 p. |
artikel |
12 |
Contaminantminduced endocrinedisruption in wildlife
|
Guillette Jr, L.J. |
|
2000 |
10 |
S2 |
p. S45-S50 6 p. |
artikel |
13 |
Decreased plasma cholesterol esterificationand cholesteryl ester transfer in patients with hypopituitarism receiving glucocorticoid replacement therapy
|
Beentjes, J.A.M. |
|
2000 |
10 |
S2 |
p. S145- 1 p. |
artikel |
14 |
Determinants for body image and coping inpatients with Turner syndrome
|
Haverkamp, F. |
|
2000 |
10 |
S2 |
p. S165- 1 p. |
artikel |
15 |
Does the age at onset of growth hormonedeficiency have an impact on cardiac performance?
|
Colao, A. |
|
2000 |
10 |
S2 |
p. S151- 1 p. |
artikel |
16 |
Effect of growth hormone deficiency on prostate size
|
Colao, A. |
|
2000 |
10 |
S2 |
p. S155- 1 p. |
artikel |
17 |
Effect of growth hormone (GH) therapy andinsulin-like growth factor I on lung function and maximal oxygen consumption in children with GH deficiency
|
Chaussain, M. |
|
2000 |
10 |
S2 |
p. S150- 1 p. |
artikel |
18 |
Effect of zinc administration on insulin-likegrowth factor I, haemoglobin and neonatal birth weight in pregnant women
|
Nishiyama, S. |
|
2000 |
10 |
S2 |
p. S159- 1 p. |
artikel |
19 |
Effects of growth hormone (GH) therapy on bone metabolism in patients with adult-onset GH deficiency: A 2-year randomized, controlled trial
|
Bex, M. |
|
2000 |
10 |
S2 |
p. S160- 1 p. |
artikel |
20 |
Effects of growth hormone on boneand muscle
|
Lissett, C.A. |
|
2000 |
10 |
S2 |
p. S95-S101 7 p. |
artikel |
21 |
Effects of growth hormone treatmentin children with Prader-Willi syndrome
|
Lee, P.D.K. |
|
2000 |
10 |
S2 |
p. S75-S79 5 p. |
artikel |
22 |
Effects of recombinant human growth hormone in catabolic adults with chronic renal failure
|
Mehls, O. |
|
2000 |
10 |
S2 |
p. S31-S37 7 p. |
artikel |
23 |
Effects of the growth hormone (GH) secretagogueipamorelin on body weight gain in GH-deficient lit/lit mice
|
Dickson, S.L. |
|
2000 |
10 |
S2 |
p. S169- 1 p. |
artikel |
24 |
Fertile Turner syndrome and gonadotropin-producing pituitary macroadenoma
|
Ojima, M. |
|
2000 |
10 |
S2 |
p. S166- 1 p. |
artikel |
25 |
Follow-up of treated acromegaly: Similarities and differences in assessing the response to different primary treatment modalities
|
Sheppard, M.C. |
|
2000 |
10 |
S2 |
p. S115-S118 4 p. |
artikel |
26 |
Foreword
|
Baumann, Gerhard |
|
2000 |
10 |
S2 |
p. iii- 1 p. |
artikel |
27 |
Growth hormone and ageing
|
Johannsson, G. |
|
2000 |
10 |
S2 |
p. S25-S30 6 p. |
artikel |
28 |
Growth hormone, burns and tissue healing
|
Lal, S.O. |
|
2000 |
10 |
S2 |
p. S39-S43 5 p. |
artikel |
29 |
Growth hormone (GH) replacement therapy for1 year does not alter colonic epithelial cell proliferation in GH-deficient adults
|
Beentjes, J.A.M. |
|
2000 |
10 |
S2 |
p. S156- 1 p. |
artikel |
30 |
Growth hormone, insulin-like growthfactor I and cognitive function in adults
|
van Dam, P.S. |
|
2000 |
10 |
S2 |
p. S69-S73 5 p. |
artikel |
31 |
Growth hormone, insulin-like growthfactor I and the CNS: Localization, function and mechanism of action
|
Lobiezz, P.E. |
|
2000 |
10 |
S2 |
p. S51-S56 6 p. |
artikel |
32 |
Growth hormone therapy for Prader-Willi and Down syndromes: A post-modern medical dilemma
|
Lantos, J.D. |
|
2000 |
10 |
S2 |
p. S93-S94 2 p. |
artikel |
33 |
Growth hormone therapy improves body composition in adults with Prader-Willi syndrome: A preliminary report
|
Höybye, C. |
|
2000 |
10 |
S2 |
p. S139- 1 p. |
artikel |
34 |
Growth hormone therapy in youngchildren with Down syndrome and a clinical comparison of Down and Prader-Willi syndromes
|
Annerén, G. |
|
2000 |
10 |
S2 |
p. S87-S91 5 p. |
artikel |
35 |
Growth hormone treatment of post-menopausalwomen with osteoporosis
|
Landin-Wilhelmsen, K. |
|
2000 |
10 |
S2 |
p. S161- 1 p. |
artikel |
36 |
Growth in Japanese children receiving peritoneal dialysis
|
Wada, N. |
|
2000 |
10 |
S2 |
p. S164- 1 p. |
artikel |
37 |
Growth patterns and skeletal features in patientswith pseudouatosomal deletions involving the SHOX gene
|
Ono, T. |
|
2000 |
10 |
S2 |
p. S171- 1 p. |
artikel |
38 |
Gs alpha mutations and their clinicalmanifestations in acromegaly
|
Susaki, N. |
|
2000 |
10 |
S2 |
p. S172- 1 p. |
artikel |
39 |
Hormonal changes during growth hormone replacement therapy: Gender-related differences
|
Krzyzanowska, B. |
|
2000 |
10 |
S2 |
p. S135- 1 p. |
artikel |
40 |
Hypothalamic-pituitary tumour surveillance imaging in patients receiving growth hormone replacement
|
Drake, W.M. |
|
2000 |
10 |
S2 |
p. S153- 1 p. |
artikel |
41 |
Inflammatory cytokines and acquiredgrowth hormone resistance
|
von Laue, S. |
|
2000 |
10 |
S2 |
p. S9-S14 6 p. |
artikel |
42 |
Inhibitory effect of growth hormone on leptinexpression in the fat tissues of fatty Zucker rats
|
Tsushima, T. |
|
2000 |
10 |
S2 |
p. S171- 1 p. |
artikel |
43 |
Insulin-like growth factor I and bone: From mouse to man
|
Beamer, W.G. |
|
2000 |
10 |
S2 |
p. S103-S105 3 p. |
artikel |
44 |
Insulin-like growth factor signalling pathways inrat hepatic stellate cells are important for DNA synthesis and hepatocyte growth factor production
|
Skrtic, S. |
|
2000 |
10 |
S2 |
p. S168- 1 p. |
artikel |
45 |
Interrelationships between growthhormone and sleep
|
Van Cauter, E. |
|
2000 |
10 |
S2 |
p. S57-S62 6 p. |
artikel |
46 |
In vitro studies of insulin-like growthfactor I and bone
|
Conover, C.A. |
|
2000 |
10 |
S2 |
p. S107-S110 4 p. |
artikel |
47 |
Liver-derived insulin-like growth factor I is aregulator of the growth hormone secretion pattern in mice
|
Wallenius, K. |
|
2000 |
10 |
S2 |
p. S168- 1 p. |
artikel |
48 |
Long-standing growth hormone (GH) deficiency after pituitary ablation in type 1 diabetes mellitus: Experience with GH replacement therapy
|
Simpson, H.L. |
|
2000 |
10 |
S2 |
p. S163- 1 p. |
artikel |
49 |
Long-term growth hormone therapy and glucose tolerance
|
Ueyama, N. |
|
2000 |
10 |
S2 |
p. S140- 1 p. |
artikel |
50 |
Long-term therapy with insulin-like growth factorI normalizes glucose metabolism and growth retardation in a patient with leprechaunism
|
Abe, S. |
|
2000 |
10 |
S2 |
p. S163- 1 p. |
artikel |
51 |
Low-dose growth hormone (GH) replacement therapy improves vascular reactivity in adults with GH deficiency
|
Christ, E.R. |
|
2000 |
10 |
S2 |
p. S152- 1 p. |
artikel |
52 |
Pegvisomant: A growth hormonereceptor antagonist for the treatment of acromegaly
|
Parkinson, C. |
|
2000 |
10 |
S2 |
p. S119-S123 5 p. |
artikel |
53 |
Pulsatility of growth hormone (GH) signalling in liver cells: Role of the JAK-STAT5b pathway in GH action
|
Choi, H.K. |
|
2000 |
10 |
S2 |
p. S1-S8 8 p. |
artikel |
54 |
Reduction in normal liver growth in interleukin-6-deficientmice
|
Wallenius, V. |
|
2000 |
10 |
S2 |
p. S167- 1 p. |
artikel |
55 |
Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors
|
Groner, B. |
|
2000 |
10 |
S2 |
p. S15-S20 6 p. |
artikel |
56 |
Relationship between the growth hormone-insulin-like growth factor I axis and serum leptin in patients with chronic renal failure
|
Cordido, F. |
|
2000 |
10 |
S2 |
p. S162- 1 p. |
artikel |
57 |
Relationships between carbohydrate-lipid oxidation balance during exercise and the growth hormone-insulin-like growth factor I (IGF-I)-IGF-binding protein axis in trained athletes
|
Brun, J.F. |
|
2000 |
10 |
S2 |
p. S147- 1 p. |
artikel |
58 |
Relationships between insulin-like growth factor I status and blood rheology in athletes
|
Brun, J.F. |
|
2000 |
10 |
S2 |
p. S146- 1 p. |
artikel |
59 |
Serum growth hormone (GH)-binding proteincan predict the lipolytic and anabolic effects of GH treatment combined with diet restriction in obesity
|
Nam, S.Y. |
|
2000 |
10 |
S2 |
p. S141- 1 p. |
artikel |
60 |
Serum leptin in growth hormone-deficient adults: Relationship to body composition and gender effects
|
Páramo, C. |
|
2000 |
10 |
S2 |
p. S142- 1 p. |
artikel |
61 |
Similar response to growth hormone (GH)replacement therapy in men and women when the dose of GH is individualized
|
Koranyi, J. |
|
2000 |
10 |
S2 |
p. S134- 1 p. |
artikel |
62 |
Stimulated growth hormone secretion in elderly men after reduction of free fatty acids by acipimox
|
van Dam, P.S. |
|
2000 |
10 |
S2 |
p. S138- 1 p. |
artikel |
63 |
Studies of high-density lipoprotein kinetics in growth hormone-deficient patients with hypopituitarism
|
Kearney, T. |
|
2000 |
10 |
S2 |
p. S143- 1 p. |
artikel |
64 |
The acid-labile subunit of the 150-kDa insulin-likegrowth factor complex in the evaluation of growth hormone deficiency
|
Garrone, S. |
|
2000 |
10 |
S2 |
p. S158- 1 p. |
artikel |
65 |
The effects of growth hormone (GH) oncyclophosphamide-induced testicular dysfunction in GH-deficient rats
|
Ohta, M. |
|
2000 |
10 |
S2 |
p. S170- 1 p. |
artikel |
66 |
The influence of growth hormone on glucagon-like peptide 1 secretion in hypophysectomized rats
|
Kitayama, N. |
|
2000 |
10 |
S2 |
p. S172- 1 p. |
artikel |
67 |
The psychological consequences and quality of life in adults with growth hormone deficiency
|
McGauley, G. |
|
2000 |
10 |
S2 |
p. S63-S68 6 p. |
artikel |
68 |
The question of a link between insulin-like growth factor physiology and neoplasia
|
Pollak, M. |
|
2000 |
10 |
S2 |
p. S21-S24 4 p. |
artikel |
69 |
The role of altered high-density lipoproteins in the low plasma lecithin cholesterol acyltransferase and lipid transfer protein activity found in growth hormone-deficient men with acromegaly
|
Beentjes, J.A.M. |
|
2000 |
10 |
S2 |
p. S144- 1 p. |
artikel |
70 |
The use of longmacting somatostatinanalogues in acrornegaly
|
Jenkins, P.J. |
|
2000 |
10 |
S2 |
p. S111-S114 4 p. |
artikel |